BlackRock, Invesco, Deutsche, PIMCO, Lord Abbett and UTI Goldfinch were the fund sponsors gaining approval for new products in September.
CCR Monthly Approval Report – August 2018
September 12, 2018 by
A total of 21 products were added in the month from 12 different asset managers: Baillie Gifford, Fidelity, HSBC, Janus Henderson, John Hancock, Apollo, Audax, Cinven, EQT, Lone Star, NB and Platinum.
CCR Monthly Approval Report – July 2018
July 31, 2018 by
A total of 45 products were added in the month from 14 different asset managers: State Street, iShares, AB, AZ Multi Asset, Barings, BMO, JP Morgan, Morgan Stanley, Ares, Coller, Crescent, Gelman, LGT and Vista.
CCR Monthly Approval Report – June 2018
July 2, 2018 by
Seven mutual funds, 20 ETFs and three alternatives were added in June to the list of approved instruments eligible to receive allocations from Chilean Pension Managers (AFPs).
CCR Monthly Approval Report – May 2018
May 31, 2018 by
The CCR approved 10 alternatives products from Apax Partners, BlackRock, Hamilton Lane, Partners Group, Kohlberg Kravis Roberts & Co., PineBridge and Warburg Pincus.
CCR Monthly Approval Report – April 2018
May 9, 2018 by
Lombard Odier led with 10 mutual funds registered in the month, while AZ Fund followed with three of its own products. Eleven other mutual funds managers and ETFs sponsors completed the list with one product each.
CCR Monthly Approval Report – March 2018
April 3, 2018 by
Evli led with nine funds registered in the month, while Goldman Sachs (2), Invesco (2), Schroder (1), Deutsche (1), BNY Mellon (1), Pictet (1), and Lyxor (1) won approval for their mutual fund products.
CCR Monthly Approval Report – February 2018
March 20, 2018 by
Deutsche, Nordea, and Acadian each had two of their mutual funds registered, while Investec, Nomura and Lyxor followed, each with one product approved.
CCR Monthly Approval Report – January 2018
February 12, 2018 by
Legg Mason, Invesco, Natixis, Lyxor, and Degroof Petercam were the managers registering products in January 2018.
CCR Monthly Approval Report – December 2017
January 3, 2018 by
Products from HSBC, Lyxor, Aberdeen and others won approval, as did the first alternatives products from Carlyle Group, Oaktree Capital and Intermediate Capital Group.
